HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jocelyn F Bautista Selected Research

ezogabine (retigabine)

10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jocelyn F Bautista Research Topics

Disease

6Epilepsy (Aura)
10/2018 - 07/2005
4Generalized Epilepsy
10/2018 - 07/2018
4Seizures (Absence Seizure)
10/2018 - 07/2018
4Partial Epilepsies (Epilepsy, Partial)
10/2018 - 07/2018
2Juvenile Myoclonic Epilepsy
10/2018 - 07/2018
2Absence Epilepsy (Childhood Absence Epilepsy)
10/2018 - 07/2018
1Lennox Gastaut Syndrome
10/2018
1Cognitive Dysfunction
01/2018
1Autism Spectrum Disorder
09/2013
1Generalized Epilepsy and Paroxysmal Dyskinesia
07/2005
1Channelopathies
07/2005
1Movement Disorders (Movement Disorder)
07/2005

Drug/Important Bio-Agent (IBA)

5Anticonvulsants (Antiepileptic Drugs)IBA
10/2018 - 01/2018
5Topiramate (Topamax)FDA LinkGeneric
10/2018 - 01/2018
4VigabatrinFDA Link
10/2018 - 07/2018
4Pregabalin (Lyrica)FDA Link
10/2018 - 07/2018
4ezogabine (retigabine)IBA
10/2018 - 07/2018
4Lamotrigine (Lamictal)FDA LinkGeneric
10/2018 - 07/2018
4eslicarbazepineIBA
10/2018 - 07/2018
4Levetiracetam (Keppra)FDA LinkGeneric
10/2018 - 07/2018
4Zonisamide (Zonegran)FDA LinkGeneric
10/2018 - 07/2018
4Clobazam (HR 376)IBA
10/2018 - 07/2018
4perampanelIBA
10/2018 - 07/2018
4rufinamideFDA Link
10/2018 - 07/2018
4Oxcarbazepine (Trileptal)FDA LinkGeneric
10/2018 - 07/2018
4LacosamideFDA Link
10/2018 - 07/2018
2Gabapentin (Neurontin)FDA LinkGeneric
10/2018 - 07/2018
2Tiagabine (Gabitril)FDA Link
10/2018 - 07/2018
2Felbamate (Felbatol)FDA Link
10/2018 - 07/2018
2Ethosuximide (Zarontin)FDA LinkGeneric
10/2018 - 07/2018
2Valproic Acid (Depakote)FDA LinkGeneric
10/2018 - 07/2018
1Proteins (Proteins, Gene)FDA Link
09/2013
1CalciumIBA
07/2005
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
07/2005
1PotassiumIBA
07/2005

Therapy/Procedure

2Therapeutics
10/2018 - 07/2018